Certified Clinical Research Professional
(CCRP) Practice Exam Questions And
Correct Answers (Verified Answers) Plus
Rationales 2025|2026 Q&A | Instant
Download Pdf
1. The primary purpose of Good Clinical Practice (GCP) is to:
A. Reduce trial costs
B. Ensure quick recruitment
C. Protect human subjects and ensure data integrity
D. Speed up drug approval
Rationale: GCP guidelines are designed to protect the rights, safety, and
well-being of trial subjects and ensure the credibility of clinical data.
2. Which document outlines the objectives, design, and methodology of a
clinical trial?
,A. Case report form
B. Informed consent form
C. Protocol
D. Investigator’s brochure
Rationale: The protocol is the core document describing the trial’s purpose,
methods, and procedures.
3. Who is responsible for ensuring that a clinical trial is conducted according
to the approved protocol?
A. Sponsor
B. CRO
C. Principal Investigator (PI)
D. Ethics committee
Rationale: The PI is directly responsible for trial conduct at the site in
accordance with the protocol.
4. What is the main role of an Institutional Review Board (IRB)/Ethics
Committee (EC)?
A. Monitor data collection
B. Protect the rights and welfare of human subjects
C. Approve marketing materials
D. Recruit participants
,Rationale: The IRB/EC ensures that ethical standards and participant
protections are maintained.
5. The document that provides comprehensive clinical and nonclinical data
about an investigational product is the:
A. Protocol
B. Investigator’s Brochure
C. Case report form
D. Study report
Rationale: The Investigator’s Brochure summarizes data on the
investigational product relevant to human studies.
6. Source documents are:
A. Translations of CRFs
B. Copies of GCP guidelines
C. Original records containing data collected during the trial
D. Published articles
Rationale: Source documents are the first place data are recorded and
serve as evidence for verification.
7. A protocol deviation occurs when:
A. The study drug expires
, B. The site closes
C. The study procedure differs from the approved protocol
D. The subject withdraws consent
Rationale: Deviations are any departures from the approved protocol’s
procedures or requirements.
8. Which of the following best describes informed consent?
A. A one-time signature
B. An ongoing process ensuring voluntary participation
C. Legal protection for the sponsor
D. A financial disclosure
Rationale: Informed consent is a continuous dialogue ensuring the
subject’s understanding and voluntary participation.
9. The sponsor is primarily responsible for:
A. Subject safety
B. Trial design, monitoring, and data management
C. Recruitment
D. Laboratory testing
Rationale: Sponsors oversee trial conduct, ensuring GCP compliance and
data reliability.
(CCRP) Practice Exam Questions And
Correct Answers (Verified Answers) Plus
Rationales 2025|2026 Q&A | Instant
Download Pdf
1. The primary purpose of Good Clinical Practice (GCP) is to:
A. Reduce trial costs
B. Ensure quick recruitment
C. Protect human subjects and ensure data integrity
D. Speed up drug approval
Rationale: GCP guidelines are designed to protect the rights, safety, and
well-being of trial subjects and ensure the credibility of clinical data.
2. Which document outlines the objectives, design, and methodology of a
clinical trial?
,A. Case report form
B. Informed consent form
C. Protocol
D. Investigator’s brochure
Rationale: The protocol is the core document describing the trial’s purpose,
methods, and procedures.
3. Who is responsible for ensuring that a clinical trial is conducted according
to the approved protocol?
A. Sponsor
B. CRO
C. Principal Investigator (PI)
D. Ethics committee
Rationale: The PI is directly responsible for trial conduct at the site in
accordance with the protocol.
4. What is the main role of an Institutional Review Board (IRB)/Ethics
Committee (EC)?
A. Monitor data collection
B. Protect the rights and welfare of human subjects
C. Approve marketing materials
D. Recruit participants
,Rationale: The IRB/EC ensures that ethical standards and participant
protections are maintained.
5. The document that provides comprehensive clinical and nonclinical data
about an investigational product is the:
A. Protocol
B. Investigator’s Brochure
C. Case report form
D. Study report
Rationale: The Investigator’s Brochure summarizes data on the
investigational product relevant to human studies.
6. Source documents are:
A. Translations of CRFs
B. Copies of GCP guidelines
C. Original records containing data collected during the trial
D. Published articles
Rationale: Source documents are the first place data are recorded and
serve as evidence for verification.
7. A protocol deviation occurs when:
A. The study drug expires
, B. The site closes
C. The study procedure differs from the approved protocol
D. The subject withdraws consent
Rationale: Deviations are any departures from the approved protocol’s
procedures or requirements.
8. Which of the following best describes informed consent?
A. A one-time signature
B. An ongoing process ensuring voluntary participation
C. Legal protection for the sponsor
D. A financial disclosure
Rationale: Informed consent is a continuous dialogue ensuring the
subject’s understanding and voluntary participation.
9. The sponsor is primarily responsible for:
A. Subject safety
B. Trial design, monitoring, and data management
C. Recruitment
D. Laboratory testing
Rationale: Sponsors oversee trial conduct, ensuring GCP compliance and
data reliability.
